Clinical trial · Interventional
Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients
Development and Effectiveness Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients: Study Protocol for a Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to create and test an online learning tool to help people with cancer improve their skills in finding and understanding health information online. The main question it aims to answer is: • Do people with cancer who use the online learning tool improve their skills more than those who don't use the tool? The investigators will test this idea in a study. The investigators will put people into different groups by chance and compare the results. 660 people with cancer will participate. These people will be chosen to represent different types of cancer. * Group 1: Uses the online learning too (3 versions) * Group 2: Uses a PDF with the same information * Control Group: Receives no intervention What Participants Will Do: Use the online tool or PDF to learn how to find reliable cancer information online. Answer questions about their digital health skills before starting, after 2 weeks, and after 8 weeks. Development: Before the start of the main study the online tool will be developed and tested. The investigators will first show a prototype of the tool to two discussion groups and use their feedback to improve it. Then, experts and people with cancer will test the final version
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| intervention group 1.1 - e-learning | Behavioral | — | UNRESOLVED |
| intervention-group 1.2 - e-learning | Behavioral | — | UNRESOLVED |
| intervention-group 1.3 - e-learning | Behavioral | — | UNRESOLVED |
| intervention-group 2 - PDF | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- type
- EXPERIMENTAL
- label
- e-learning - intervention group 1.1
- description
- Participants in intervention group 1.1 will be given access to an e-learning environment with all the persuasive primary task support elements (reduction, tunneling, rehearsal). Participants can complete the e-learning within 2 weeks. The e-learning program takes approximately 20-45 minutes to complete.
- interventionNames
- Behavioral: intervention group 1.1 - e-learning
- type
- EXPERIMENTAL
- label
- e-learning - intervention-group 1.2
- description
- Participants in intervention group 1.2 are given access to the same e-learning environment without the persuasive primary task support element, tunneling. Tunneling means that the educational content is organized step by step in separate chapters of the program. Participants can complete the e-learning within 2 weeks. The e-learning program takes approximately 20-45 minutes to complete.
- interventionNames
- Behavioral: intervention-group 1.2 - e-learning
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * cancer diagnosis * sufficient knowledge of the German language as all study content and questionnaires will be in German only * Participants must also have and be able to use a digital device (smartphone, tablet, PC, laptop, etc.) with an internet connection * Confirm consent to participate in the study Exclusion criteria: * Patients who are severely cognitively impaired due to their cancer or other illness * Patients who are unable to operate a digital device
References
Publications (0)
Data not yet available